Table 7 Multivariate analysis . Days... | American Society of Hematology

Table 7

Multivariate analysis

	Days 18-60		Days 61-120		Days 121-365		More than 1 year
	P	RR	P	RR	P	RR	P	RR
First-line therapy
Age*	.037	1.20	.001	1.39	<.001	1.40	.513
FLT3-LM	.039	1.82	.245	1.37	.099	1.35	.583
NPM1 level†	.097	0.021	.021	1.10	< .001	1.12	< .001	1.15
After second-line therapy
FLT3*	na	na	na	na	.022	14.989	ns	ns
NPM1 level*	na	na	na	na	.012	0.398	.024	1.266
After alloSCT
Age*	na	na	.819	na	.515	ns	na	na
NPM1 ratio†	na	na	.065	1.065	.024	1.062	na	na

	Days 18-60		Days 61-120		Days 121-365		More than 1 year
	P	RR	P	RR	P	RR	P	RR
First-line therapy
Age*	.037	1.20	.001	1.39	<.001	1.40	.513
FLT3-LM	.039	1.82	.245	1.37	.099	1.35	.583
NPM1 level†	.097	0.021	.021	1.10	< .001	1.12	< .001	1.15
After second-line therapy
FLT3*	na	na	na	na	.022	14.989	ns	ns
NPM1 level*	na	na	na	na	.012	0.398	.024	1.266
After alloSCT
Age*	na	na	.819	na	.515	ns	na	na
NPM1 ratio†	na	na	.065	1.065	.024	1.062	na	na

Significant parameters are presented in bold type.

alloSCT indicates allogeneic stem cell transplantation; na: not applicable; ns, not significant; and RR, relative risk.

RR for 10-year period.

RR for 100-fold increase.